Search

everythinglearnresearchcommunity

for

Search:↓

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.